Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05371054 |
|---|---|
| Brief Title: | Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies |
| First Submitted : | May 11, 2022 |
| First Submitted that Met QC Criteria : | May 11, 2022 |
| First Posted : | May 12, 2022 |
| Last Update Submitted that Met QC Criteria : | April 12, 2024 |
| Last Update Posted : | April 15, 2024 |